Nebula Genomics

Nebula Genomics

Created using Figma
Created using Figma
Pharma and biotech companies spend billions of dollars each year to acquire genomic data. Scientists need large genomic datasets to identify causes of disease and develop cures. However, growth of the genomic data market is hindered by small data quantities, data fragmentation, lack of data standardization and slow data acquisition. Nebula Genomics will leverage blockchain technology to eliminate the middleman and empower people to own their personal genomic data. This will effectively lower sequencing costs and enhance data privacy, resulting in growth of genomic data. Our open protocol will leverage the genomic data growth by enabling data buyers to efficiently aggregate standardized data from many individuals and genomic databanks.
Risk: Very High
Jun, 2018
Jun, 2018
100% completed
Raised funds - no Data
past
Token Details
Accepted Currencies
ETH
Company Details
Registered Country
United States
Additional Details
KYC
Yes
Categories
Health, Big Data

About Nebula Genomics

The first human genome was sequenced in 2001 at a cost of $3 billion. Today, human genome sequencing costs less than $1000, and in a few years the price will drop below $100. Thus, personal genome sequencing will soon be widely adopted as it enables better diagnosis, disease prevention, and personalized therapies. Furthermore, if genomic data is shared with researchers, the causes of many diseases will be identified and new drugs developed. These opportunities are creating a genomic data market worth billions of dollars.

Nebula Genomics seeks to lead this emerging market by understanding and overcoming key obstacles. We will spur genomic data growth by significantly reducing the costs of personal genome sequencing, enhancing genomic data protection, enabling buyers to efficiently acquire genomic data, and addressing the challenges of genomic big data. We will accomplish this through decentralization, cryptography, and utilization of the blockchain.

SEQUENCING COSTS - The Nebula peer-to-peer network will enable data buyers to acquire genomic data directly from data owners without middlemen. This will enable data owners to receive sequencing subsidies from data buyers and profit from sharing their data. Reducing sequencing costs will accelerate growth of genomic data.

DATA PROTECTION - Data owners will privately store their genomic data and control access to it. Shared data will be protected through zero-trust, encryption-based secure computing. Data owners will remain anonymous, while data buyers will be required to be fully transparent about their identity. The Nebula blockchain will immutably store all data transaction records. Addressing data privacy concerns will likewise accelerate growth of genomic data.

DATA ACQUISITION - The Nebula network will aggregate genomic data from individuals and genomic databanks and thereby address the problem of genomic data fragmentation. Direct communication with data owners and a smart survey tool will enable data buyers to collect high quality trait information. Utilization of standardized data formats will facilitate data curation. Smart contracts will automate and thereby accelerate data purchases.

GENOMIC BIG DATA - Genomic big data is projected to outgrow video and text data within the next few years. Through decentralized data storage, flexible utilization of available computing power and efficient file transfers enabled by space-efficient data encoding, the Nebula network will absorb the forthcoming data explosion.

Activity

Followers:
25 980
VERY HIGH
Tweets:
558
VERY HIGH
30 Days Growth:
-48
Members:
2 162
MEDIUM
30 Days Growth:
-80

Nebula Genomics Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

George Church
Co-founder
unverified
Dennis Grishin
Co-founder
unverified
Kamal Obbad
Co-founder
unverified
Armon Rahim
Growth Lead
unverified
Kevin Quinn
Engineer
unverified

Advisors

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Mirza Cifric
Advisor
unverified
Preston Estep
Advisor
unverified
Yining Zhao
Advisor
unverified
Drew Volpe
Advisor
unverified
Joe Urgo
Advisor
unverified
D. A. Wallach
Advisor
unverified

Nebula Genomics Last News

1.88
negative
5.0 13
ICO Profile Vision Activity Potential Product Team

Nebula Genomics Reviews

ICO Pantera
A

Advantages.
1. A very competent gene sequencing company called `veritas` is the parent company.
2. It provides genetic sequencing services rather than simple genetic testing services. It is recognized that it is promising market, and it can be said that there are almost no rivals on ICO market.
3. Team is strong and institutional investors who are solid. Advisors, especially George Church, are prominent.
A complementary point
1. There are strong market competitors including 23andme.
2. There are not many developers yet, and they are showing weakness in marketing. Active marketing is especially important in the coin market.
3. No code has been published yet, and no tokensale has been published.

Read More
Crypto Sherlock
6.8
Read More
  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.
Planning an ICO? We can help with a wide range of support for all stages of your ICO